https://www.selleckchem.com/products/ho-3867.html
ls of efficacy. • There is a wide variety in deployment strategies, pricing models, and CE marking class of AI products for radiology. • Interest in radiomics and machine learning is steadily increasing and is reflected both in research output and number of commercially available solutions.• Currently available commercial products using machine learning are often supported by limited evidence of clinical usefulness and studies are often of low methodological quality.• Ethical and regulatory issues remain open and hinder implementation o
Like
Comment
Share
